These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8383293)

  • 21. Deposition of amyloid fibrils promotes cell-surface accumulation of amyloid beta precursor protein.
    Heredia L; Lin R; Vigo FS; Kedikian G; Busciglio J; Lorenzo A
    Neurobiol Dis; 2004 Aug; 16(3):617-29. PubMed ID: 15262274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trafficking of Alzheimer's disease-related membrane proteins and its participation in disease pathogenesis.
    Suzuki T; Araki Y; Yamamoto T; Nakaya T
    J Biochem; 2006 Jun; 139(6):949-55. PubMed ID: 16788045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The amyloid peptide and its precursor in Alzheimer's disease.
    Octave JN
    Rev Neurosci; 1995; 6(4):287-316. PubMed ID: 8845971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Excess of nicastrin in brain results in heterozygosity having no effect on endogenous APP processing and amyloid peptide levels in vivo.
    Brijbassi S; Amtul Z; Newbigging S; Westaway D; St George-Hyslop P; Rozmahel RF
    Neurobiol Dis; 2007 Feb; 25(2):291-6. PubMed ID: 17071095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell biology of the beta-amyloid precursor protein and the genetics of Alzheimer's disease.
    Selkoe DJ
    Cold Spring Harb Symp Quant Biol; 1996; 61():587-96. PubMed ID: 9246485
    [No Abstract]   [Full Text] [Related]  

  • 26. Prolonged stress will induce Alzheimer's disease in elderly people by increased release of homocysteic acid.
    Hasegawa T
    Med Hypotheses; 2007; 69(5):1135-9. PubMed ID: 17499446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biochemical and molecular study of amyloid protein A4 deposited in senile plaques].
    Octave JN; de Sauvage F; Macq AF; Maloteaux JM
    Acta Neurol Belg; 1989; 89(3-4):276-8. PubMed ID: 2576496
    [No Abstract]   [Full Text] [Related]  

  • 28. [The neuronal cytoplasmic adaptor protein X11L is involved in APP metabolism].
    Zhao NQ; Li JG; Yang XR
    Sheng Li Ke Xue Jin Zhan; 2010 Feb; 41(1):47-51. PubMed ID: 21417016
    [No Abstract]   [Full Text] [Related]  

  • 29. Neuroinflammatory cytokine signaling and Alzheimer's disease.
    Griffin WS
    N Engl J Med; 2013 Feb; 368(8):770-1. PubMed ID: 23425171
    [No Abstract]   [Full Text] [Related]  

  • 30. Endogenous ADP-ribosylation of phosphoprotein B-50/GAP-43 and other neuronal substrates.
    Zwiers H; Hollenberg MD; McLean KN; Philibert KD
    Adv Exp Med Biol; 1997; 419():279-88. PubMed ID: 9193667
    [No Abstract]   [Full Text] [Related]  

  • 31. Receptor-G-protein signalling in Alzheimer's disease.
    Cowburn RF; O'Neill C; Bonkale WL; Ohm TG; Fastbom J
    Biochem Soc Symp; 2001; (67):163-75. PubMed ID: 11447833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The neuropil and GAP-43/B-50 in normally aging and Alzheimer's disease human brain.
    Coleman PD; Rogers KE; Flood DG
    Prog Brain Res; 1991; 89():263-9. PubMed ID: 1839068
    [No Abstract]   [Full Text] [Related]  

  • 33. Alzheimer's disease: Attack on amyloid-β protein.
    Reiman EM
    Nature; 2016 Sep; 537(7618):36-7. PubMed ID: 27582214
    [No Abstract]   [Full Text] [Related]  

  • 34. [Genetic aspects of Alzheimer's disease].
    Tateishi J
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):1037-40. PubMed ID: 3152085
    [No Abstract]   [Full Text] [Related]  

  • 35. Alzheimer's disease: neurodevelopment converges with neurodegeneration.
    Bothwell M; Giniger E
    Cell; 2000 Aug; 102(3):271-3. PubMed ID: 10975517
    [No Abstract]   [Full Text] [Related]  

  • 36. Abnormalities in brain glucose utilization and its impact on cellular and molecular mechanisms in sporadic dementia of Alzheimer type.
    Hoyer S
    Ann N Y Acad Sci; 1993 Sep; 695():77-80. PubMed ID: 8239317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GAP-43 immunoreactivity is detected in the nerve terminals of patients with amyotrophic lateral sclerosis.
    Ueki A; Namba Y; Otsuka M; Okuno M; Nishimura M; Oda M; Ikeda K
    Ann Neurol; 1993 Feb; 33(2):226-7. PubMed ID: 8434888
    [No Abstract]   [Full Text] [Related]  

  • 38. G-protein coupled signal transduction systems in the Alzheimer's disease brain.
    O'Neill C; Fowler CJ; Winblad B; Cowburn RF
    Biochem Soc Trans; 1994 Feb; 22(1):167-71. PubMed ID: 8206216
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapeutic approaches targeted at the amyloid proteins in Alzheimer's disease.
    Caputo CB; Scott CW; Sobel IR; Sygowski LA; Wischik CM; Brunner WF
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():414A-415A. PubMed ID: 1498896
    [No Abstract]   [Full Text] [Related]  

  • 40. Amyloidosis in aging and Alzheimer's disease.
    Price DL; Walker LC; Martin LJ; Sisodia SS
    Am J Pathol; 1992 Oct; 141(4):767-72. PubMed ID: 1415474
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.